Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-like Peptide-1”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00638313
What this trial is testing

Single-Dose Study Of PF-04603629 In Type 2 Diabetic Subjects

Who this might be right for
Diabetes Mellitus, Type 2
Pfizer 71
Not applicableWithdrawnNCT06982378
What this trial is testing

GLP-1 RA on Liver OMICS in MASLD

Who this might be right for
NAFLDDiabetesObesity
Medical College of Wisconsin
Large-scale testing (Phase 3)Study completedNCT00993720
What this trial is testing

Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus
Hvidovre University Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT06973720
What this trial is testing

A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or Overweight

Who this might be right for
ObesityOverweight or Obesity
Pfizer 268
Not applicableStudy completedNCT02036710
What this trial is testing

Location of GLP-1 Release

Who this might be right for
Obesity
University of Minnesota 12
Not applicableStudy completedNCT00876213
What this trial is testing

Amylin and Glucagon-Like Peptide-1 (GLP-1): Influence on Gastric Emptying, Appetite and Food Intake in Humans

Who this might be right for
Diabetes
Hvidovre University Hospital 23
Testing effectiveness (Phase 2)UnknownNCT05751720
What this trial is testing

Effect on Non-Alcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus With Gastric Inhibitory Polypeptide/Glucagon Like Peptide-1 Analogue

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-alcoholic SteatohepatitisType 2 Diabetes+1 more
Dr Adnan Agha 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04019197
What this trial is testing

Effects of Semaglutide in HIV-Associated Lipohypertrophy

Who this might be right for
HIV/AIDSLipohypertrophyObesity
Case Western Reserve University 108
Not applicableLooking for participantsNCT07760896
What this trial is testing

The GLOW Study: GLP-1 and Lifestyle for Optimal Wellness

Who this might be right for
Wellness
Saundra Jain 200
Not applicableStudy completedNCT00832741
What this trial is testing

Incretin Hormones in Type-1 Diabetes Mellitus Glycemic Response in Type-1 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes
Hvidovre University Hospital 30
Post-approval studies (Phase 4)Study completedNCT01455441
What this trial is testing

The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Tina Vilsboll 40
Post-approval studies (Phase 4)Study completedNCT01524705
What this trial is testing

FLuctuATion Reduction With inSULin and Glp-1 Added togetheR (FLAT-SUGAR)

Who this might be right for
Type 2 Diabetes
University of Washington 102
Post-approval studies (Phase 4)Looking for participantsNCT06132477
What this trial is testing

Impact GLP-1 Agonists Following Bariatric

Who this might be right for
Morbid ObesityMetabolic SyndromeDiabetes Mellitus+2 more
University of Missouri-Columbia 150
Not applicableLooking for participantsNCT06654219
What this trial is testing

Protective Benefits of a Clear Liquid Diet on Residual Gastric Content in Patients Taking Glucagon Like Peptide-1 Receptor (GLP-1 RA) Agonist Prior to Anesthesia

Who this might be right for
Pulmonary Aspiration
The University of Texas Health Science Center, Houston 136
Not applicableUnknownNCT02671864
What this trial is testing

Incretin-mimetic Hypoglycemic Drugs and Severe Retinopathy

Who this might be right for
Type 2 Diabetes
Assistance Publique - Hôpitaux de Paris 7,200
Post-approval studies (Phase 4)Looking for participantsNCT07314684
What this trial is testing

GLP1-RAs Effects on Inflammatory and Endothelial Biomarkers in T2DM

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Federico II University 80
Testing effectiveness (Phase 2)Looking for participantsNCT05822609
What this trial is testing

Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes

Who this might be right for
Diabetic Kidney DiseaseType 1 Diabetes
University of Washington 60
Not applicableStudy completedNCT00775684
What this trial is testing

Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass

Who this might be right for
Pre-diabetesType 2 Diabetes
University of Pennsylvania 47
Not applicableStudy completedNCT00843232
What this trial is testing

Characterization of the Incretinpathy in Type 2 Diabetes Initiated After Sixty Years Old

Who this might be right for
Diabetes Mellitus, Type 2Insulin Resistance
University of Campinas, Brazil 24
Early research (Phase 1)Study completedNCT02683187
What this trial is testing

DPP4 Inhibition & Beta Cell Function

Who this might be right for
Healthy
David D'Alessio, M.D. 40
Next Page